131 related articles for article (PubMed ID: 11513550)
1. Relationship between complement activation and renal deposition of immune complexes made with IgG2a monoclonal antibodies.
Gonzalez ML; Waxman FJ
Clin Immunol; 2001 Sep; 100(3):362-71. PubMed ID: 11513550
[TBL] [Abstract][Full Text] [Related]
2. Glomerular deposition of immune complexes made with IgG2a monoclonal antibodies.
Gonzalez ML; Waxman FJ
J Immunol; 2000 Jan; 164(2):1071-7. PubMed ID: 10623858
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of IgG2A monoclonal antibodies in relation to complement deposition and renal immune complex deposition.
Gonzalez ML; Frank MB; Ramsland PA; Hanas JS; Waxman FJ
Mol Immunol; 2003 Oct; 40(6):307-17. PubMed ID: 14522012
[TBL] [Abstract][Full Text] [Related]
4. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
5. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
6. Clearance and organ localization of small DNA anti-DNA immune complexes in mice.
Emlen W; Burdick G
J Immunol; 1988 Mar; 140(6):1816-22. PubMed ID: 3257987
[TBL] [Abstract][Full Text] [Related]
7. Mutant monoclonal antibodies with select alteration in complement activation ability. Impact on immune complex functions in vivo.
Nose M; Okuda T; Gidlund M; Ramstedt U; Okada N; Okada H; Heyman B; Kyogoku M; Wigzell H
J Immunol; 1988 Oct; 141(7):2367-73. PubMed ID: 3171176
[TBL] [Abstract][Full Text] [Related]
8. Experimental glomerulonephritis induced by immune complexes of monoclonal antibodies produced by immunoglobulin class-switch variants.
Chen XM; Tanaka T; Kobayashi Y; Shigematsu H; Okumura K
Lab Invest; 1987 Dec; 57(6):665-72. PubMed ID: 3695412
[TBL] [Abstract][Full Text] [Related]
9. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
Skogh T; Stendahl O
Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes.
Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J
Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107
[TBL] [Abstract][Full Text] [Related]
12. Effect of H chain V region on complement activation by immobilized immune complexes.
Horgan C; Brown K; Pincus SH
J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
[TBL] [Abstract][Full Text] [Related]
13. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor.
Yokoyama I; Waxman F
Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
Golan MD; Burger R; Loos M
J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
[TBL] [Abstract][Full Text] [Related]
15. Ig N-glycan orientation can influence interactions with the complement system.
White KD; Cummings RD; Waxman FJ
J Immunol; 1997 Jan; 158(1):426-35. PubMed ID: 8977219
[TBL] [Abstract][Full Text] [Related]
16. Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.
Cosio FG; Birmingham DJ; Sexton DJ; Hebert LA
J Immunol; 1987 Apr; 138(8):2587-92. PubMed ID: 3559208
[TBL] [Abstract][Full Text] [Related]
17. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
Li X; Egorina E; Bertelsen EL; Dahlen H; Hannestad K
Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
[TBL] [Abstract][Full Text] [Related]
18. The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.
Taylor PR; Pickering MC; Kosco-Vilbois MH; Walport MJ; Botto M; Gordon S; Martinez-Pomares L
Eur J Immunol; 2002 Jul; 32(7):1888-96. PubMed ID: 12115608
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli.
Waxman FJ; Hebert LA; Cosio FG; Smead WL; VanAman ME; Taguiam JM; Birmingham DJ
J Clin Invest; 1986 Jan; 77(1):82-9. PubMed ID: 3944261
[TBL] [Abstract][Full Text] [Related]
20. In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits.
Brown DL; Harkiss GD
Clin Exp Immunol; 1981 Feb; 43(2):231-9. PubMed ID: 6974064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
